157 results
Page 3 of 8
8-K
EX-99.1
wuanlok 4n2ja
25 Feb 21
Agios Reports Fourth Quarter and Full Year 2020 Financial Results
7:17am
DEFM14A
5qgox2oe ttt5zg300y
11 Feb 21
Proxy related to merger
4:19pm
PREM14A
qsp ff8l61ld
29 Jan 21
Preliminary proxy related to merger
4:22pm
8-K
EX-99.1
z88 flmf9t7icev
29 Jan 21
Index to Consolidated Financial Statements
4:08pm
8-K
EX-99.1
qm2fc ddhv
26 Jan 21
Other Events
4:14pm
DEFA14A
0k71ge29vc2cx9srn
11 Jan 21
Additional proxy soliciting materials
7:17am
8-K
EX-99.1
jfjvseiyd0vuhdx sh9p
11 Jan 21
Agios Highlights 2021 Milestones to Accelerate and Expand Its Genetically Defined Disease Portfolio and Drive Near- and Long-Term Value Creation
7:14am
DEFA14A
zldmog
23 Dec 20
Additional proxy soliciting materials
4:52pm
DEFA14A
tkf4pb28k dj4pphz8
21 Dec 20
Additional proxy soliciting materials
5:23pm
DEFA14A
qvvmjlk9suicksl7w
21 Dec 20
Additional proxy soliciting materials
5:21pm
DEFA14A
EX-99.1
ygc1dnlhf8l 69hrud1
21 Dec 20
Additional proxy soliciting materials
7:10am
8-K
EX-99.1
tzdeg qqplud
21 Dec 20
Regulation FD Disclosure
7:04am
8-K
EX-99.1
jqe7iadrpx kof
7 Dec 20
Agios Announces Updated Data from Phase 1 Study of Mitapivat, First-in-Class PKR Activator, in Sickle Cell Disease
4:53pm
8-K
EX-99.1
xp1a 20ckapg7m
1 Dec 20
Other Events
7:46am
8-K
EX-99.1
6zwgcr1laas uyh
5 Nov 20
Agios Reports Business Highlights and Third Quarter 2020 Financial Results
7:32am
8-K
EX-99.1
dtlu7puo1kh
21 Sep 20
Other Events
7:14am
8-K
EX-99.1
rxu 836qusd5
8 Sep 20
Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs
4:09pm
8-K
al6syxzsy3oywx4b4x
8 Sep 20
Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs
4:09pm